HMN 2026: How Novel synthetic biomolecule degrades disease-related proteins
Design of IgG-BMC@MPNs for cytosolic entry and proteasome targeting. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-72967-8 Northwestern Medicine scientists have developed a novel synthetic biomolecular condensate that can degrade intracellular disease-causing proteins, providing a framework for new therapeutic approaches for a…
